{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:31:26Z","timestamp":1793280686060,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["26POST1560184"],"award-info":[{"award-number":["26POST1560184"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["24MERIT1186642"],"award-info":[{"award-number":["24MERIT1186642"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R21TR005433"],"award-info":[{"award-number":["R21TR005433"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F30HL172382"],"award-info":[{"award-number":["F30HL172382"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R35HL172107"],"award-info":[{"award-number":["R35HL172107"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.ajkd.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:01:39Z","timestamp":1790060499000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study"],"prefix":"10.1053","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-386X","authenticated-orcid":false,"given":"Guoyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara J.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2026.06.015_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.015_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrendo.2017.119","article-title":"Angiopoietin-like 3 in lipoprotein metabolism","volume":"13","author":"Kersten","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1053\/j.ajkd.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/ATVBAHA.107.151894","article-title":"Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake","volume":"27","author":"Lichtenstein","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.015_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa2404147","article-title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for mixed hyperlipidemia","volume":"391","author":"Rosenson","year":"2024","journal-title":"N Engl J Med"},{"issue":"10493","key":"10.1053\/j.ajkd.2026.06.015_bib7","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(25)00825-6","article-title":"Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b\/2a clinical studies","volume":"405","author":"Cummings","year":"2025","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"20","key":"10.1053\/j.ajkd.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"20","key":"10.1053\/j.ajkd.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","article-title":"Effects of fibrates in kidney disease: a systematic review and meta-analysis","volume":"60","author":"Jun","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/pr.2015.38","article-title":"A novel role of angiopoietin-like-3 associated with podocyte injury","volume":"77","author":"Liu","year":"2015","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.015_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2019.06.065","article-title":"Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on Adriamycin-induced nephropathy in mice","volume":"516","author":"Han","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1053\/j.ajkd.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41419-022-05313-7","article-title":"Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage","volume":"13","author":"Lv","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"issue":"49","key":"10.1053\/j.ajkd.2026.06.015_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn6068","article-title":"Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease","volume":"10","author":"Srivastava","year":"2024","journal-title":"Sci Adv"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12944-019-1052-1","article-title":"Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria","volume":"18","author":"Gao","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.015_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/path.5512","article-title":"Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway","volume":"252","author":"Shen","year":"2020","journal-title":"J Pathol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"issue":"7","key":"10.1053\/j.ajkd.2026.06.015_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program","volume":"381","author":"Denny","year":"2019","journal-title":"N Engl J Med"},{"issue":"8003","key":"10.1053\/j.ajkd.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us research program","volume":"627","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.015_bib21","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/jpm12121974","article-title":"The Penn Medicine BioBank: towards a genomics-enabled learning healthcare system to accelerate precision medicine in a diverse population","volume":"12","author":"Verma","year":"2022","journal-title":"J Pers Med"},{"issue":"7890","key":"10.1053\/j.ajkd.2026.06.015_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"issue":"6706","key":"10.1053\/j.ajkd.2026.06.015_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1182","article-title":"Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program","volume":"385","author":"Verma","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1053\/j.ajkd.2026.06.015_bib24","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41588-025-02335-7","article-title":"Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects","volume":"57","author":"Karczewski","year":"2025","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.ajkd.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"issue":"7944","key":"10.1053\/j.ajkd.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","article-title":"Overview of the BioBank Japan project: study design and profile","volume":"27","author":"Nagai","year":"2017","journal-title":"J Epidemiol"},{"issue":"6734","key":"10.1053\/j.ajkd.2026.06.015_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.adp4753","article-title":"Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants","volume":"387","author":"Liu","year":"2025","journal-title":"Science"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","article-title":"Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression","volume":"56","author":"Abedini","year":"2024","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12916-024-03700-9","article-title":"Common pitfalls in drug target Mendelian randomization and how to avoid them","volume":"22","author":"Gill","year":"2024","journal-title":"BMC Med"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.015_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajhg.2014.12.021","article-title":"Adjusting for heritable covariates can bias effect estimates in genome-wide association studies","volume":"96","author":"Aschard","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2026.06.015_bib32","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ije\/dyaa266","article-title":"Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations","volume":"50","author":"Hartwig","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.06.015_bib33","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1053\/j.ajkd.2026.06.015_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2026.06.015_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.015_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.015_bib37","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/eurheartj\/ehaa972","article-title":"Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.015_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae035","article-title":"Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk","volume":"4","author":"Landfors","year":"2024","journal-title":"Eur Heart J Open"},{"issue":"10","key":"10.1053\/j.ajkd.2026.06.015_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ajkd.2026.06.015_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119146","article-title":"The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the hen or the egg?","volume":"403","author":"Tramontano","year":"2025","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1053\/j.ajkd.2026.06.015_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1194\/jlr.M054890","article-title":"ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys","volume":"56","author":"Gusarova","year":"2015","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.015_bib42","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.120.317128","article-title":"LDL-cholesterol reduction by ANGPTL3 inhibition in mice is dependent on endothelial lipase","volume":"127","author":"Wu","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100313","article-title":"Genetic mimicry analysis reveals the specific lipases targeted by the ANGPTL3-ANGPTL8 complex and ANGPTL4","volume":"64","author":"Landfors","year":"2023","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"issue":"7675","key":"10.1053\/j.ajkd.2026.06.015_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.ajkd.2026.06.015_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"De Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib47","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1038\/s41467-021-25805-y","article-title":"Differentially expressed genes reflect disease-induced rather than disease-causing changes in the transcriptome","volume":"12","author":"Porcu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.015_bib48","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-2275(20)34218-8","article-title":"Hepatic lipase activity is lower in African American men than in white American men: effects of 5\u02b9 flanking polymorphism in the hepatic lipase gene (LIPC)","volume":"39","author":"Vega","year":"1998","journal-title":"J Lipid Res"},{"issue":"9888","key":"10.1053\/j.ajkd.2026.06.015_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"5993","key":"10.1053\/j.ajkd.2026.06.015_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1053\/j.ajkd.2026.06.015_bib51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2026.06.015_bib52","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41591-025-03872-8","article-title":"The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health","volume":"31","author":"Hirohama","year":"2025","journal-title":"Nat Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:31:39Z","timestamp":1793277099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626011212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S0272638626011212"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.06.015","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}